Nearly 116 million Americans are living with hypertension, more commonly known as high blood pressure. 20% of those patients have resistant hypertension - blood pressure that can’t be controlled - even with multiple medications. Resistant hypertension comes with serious risks for patients, including a substantially increased risk for heart attack, stroke, and kidney failure. Renal Denervation (RDN) is a minimally-invasive and potentially life-changing option for these patients.

KCTV5 talks with Dr. Steven Laster, interventional cardiologist at Saint Luke's Mid America Heart Institute and lead study principal investigator, about how Saint Luke’s has been the leading hospital in the region involved in this research and a major enroller in the RADIANCE II trial and how it helps patients with hypertension. 

Saint Luke's patient, David Taylor, shares how this procedure has been a "game-changer and a life-saver" for him. 



Related Content

Feb. 24, 2023
FOX4: Saint Luke’s Patient, Family Benefit from Genetic Testing, Encourage Others to get Tested
A Warrensburg, Missouri man credits doctors at Saint Luke’s Mid America Heart Institute for bringing genetic testing to his attention and helping his family.
Feb. 9, 2023
KSHB: Chiefs Fan Raises Awareness about American Heart Month
Lynn Schmidt, better known as Weirdwolf, brings passion, noise, and lots of heart to every Kansas City Chiefs game at Arrowhead Stadium. But his beating heart needed attention.
Feb. 23, 2023
KCTV: Atrial Fibrillation and New Treatment
Dr. Sanjaya Gupta, electrophysiologist at Saint Luke's Mid America Heart Institute, talks with KCTV about risk factors and new treatment available at Saint Luke's Atrial Fibrillation Clinic.